C-MER Medical Holdings reports share repurchase activities

C-MER Medical Holdings Limited announced a series of share repurchases, with a primary transaction on September 17, 2025, involving 160,000 ordinary shares. These shares were repurchased on the Exchange at prices ranging from HK$1.96 to HK$1.97, totaling an aggregate price paid of HK$314,800. Following this transaction, the company's total issued shares (excluding treasury shares) decreased by 160,000 to 1,244,992,870, while treasury shares increased by 160,000 to 10,568,000.

The company's board authorized repurchases under a mandate granted on May 19, 2025, permitting the repurchase of up to 125,556,087 shares. The 160,000 shares repurchased on September 17, 2025, represent 0.0128% of the issued shares (excluding treasury shares) as of the mandate date. The moratorium period for any new share issues or treasury share sales following these repurchases extends up to October 17, 2025.

Additionally, the disclosure details numerous other share repurchases for cancellation that had not yet been cancelled as of the closing balance date. These transactions occurred between July 12, 2024, and May 15, 2025, with individual repurchases ranging from 38,000 to 1,000,000 shares at various prices.